Biotech Acquisition Co Stock Number Of Shares Shorted
| BIOTDelisted Stock | USD 10.15 0.00 0.00% |
Biotech Acquisition Co fundamentals help investors to digest information that contributes to Biotech Acquisition's financial success or failures. It also enables traders to predict the movement of Biotech Stock. The fundamental analysis module provides a way to measure Biotech Acquisition's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biotech Acquisition stock.
Biotech |
Biotech Acquisition Co Company Number Of Shares Shorted Analysis
Biotech Acquisition's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
Current Biotech Acquisition Number Of Shares Shorted | 9.3 K |
Most of Biotech Acquisition's fundamental indicators, such as Number Of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biotech Acquisition Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
CompetitionBased on the recorded statements, Biotech Acquisition Co has 9.3 K of outstending shares currently sold short by investors. This is 99.84% lower than that of the Financial Services sector and significantly higher than that of the Shell Companies industry. The number of shares shorted for all United States stocks is 99.8% higher than that of the company.
Biotech Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biotech Acquisition's direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biotech Acquisition could also be used in its relative valuation, which is a method of valuing Biotech Acquisition by comparing valuation metrics of similar companies.Biotech Acquisition is currently under evaluation in number of shares shorted category among its peers.
Biotech Fundamentals
| Return On Asset | -0.0085 | |||
| Current Valuation | 290.09 M | |||
| Shares Outstanding | 23 M | |||
| Shares Owned By Institutions | 100.00 % | |||
| Number Of Shares Shorted | 9.3 K | |||
| Price To Earning | 29.21 X | |||
| Price To Book | 1.33 X | |||
| EBITDA | (6.86 M) | |||
| Net Income | (6.86 M) | |||
| Cash And Equivalents | 1.7 K | |||
| Total Debt | 153.35 K | |||
| Debt To Equity | 3.48 % | |||
| Current Ratio | 0.04 X | |||
| Book Value Per Share | (0.46) X | |||
| Cash Flow From Operations | (1.47 M) | |||
| Short Ratio | 0.05 X | |||
| Earnings Per Share | 0.26 X | |||
| Market Capitalization | 291.81 M | |||
| Total Asset | 230 | |||
| Net Asset | 230 |
About Biotech Acquisition Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biotech Acquisition Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotech Acquisition using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotech Acquisition Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Biotech Stock
If you are still planning to invest in Biotech Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biotech Acquisition's history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |